BSEBoard Meeting4d ago · 6 Nov 2026, 01:08 pm

PVP Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated financial Results for the quarter and half year ended 30th September, 2026

PVP Ventures Ltd · 517556

✦ AI SummaryResults

PVP Ventures Ltd, now known as Evervie Health Ltd, has scheduled a Board Meeting on 13th November 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

PVP Ventures Ltd - 517556 - Board Meeting Intimation for To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2026.

Attachments (1)

📄

9c455de2-eca1-46aa-bd88-477960f633d9.pdf

pdf

Download →
View document text
EVERVIE HEALTH LIMITED (Formerly known as PVP Ventures Limited) Date: 6th November, 2026 National Stock Exchange of India Limited BSE Limited The Manager, Listing Department Corporate Relationship Department Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E) Dalal Street, Fort, Mumbai - 400051 Mumbai - 400001 Equity- Symbol: PVP Equity- Scrip Code: 517556 Debt - 18PVL29A, 18PVL29 Dear Sir/Madam, Sub: Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of Evervie Health Limited (Formerly Known as PVP Ventures Limited) (“the Company”) is scheduled to be held on Friday, 13th November, 2026, inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September, 2026. As informed earlier, the trading window for dealing in the securities of the Company has been closed for all designated persons and their immediate relatives from 1st October, 2026 and shall remain closed until 48 hours after the declaration of the said financial results. Thus, the trading window shall remain closed until, 15th November, 2026. You are requested to take the above information on record. Thanking You, Yours faithfully, For Evervie Health Limited (Formerly Known as PVP Ventures Limited) Prasad V. Potluri Chairman and Managing Director DIN: 00179175 EVERVIE HEALTH LIMITED Registered Office: 9th Floor, KRM Centre, No. 2, Harrington Road, Chetpet, Chennai – 600031, Tamil Nadu. Corporate Office: 4th Floor, Punniah Plaza, Plot Nos. 83 & 84, Road No. 2, Banjara Hills, Hyderabad – 500034, Telangana. Tel: Chennai: +91 44 3028 5570 | Hyderabad: +91 40 6730 9999 CIN: L72300TN1991PLC020122 | GSTIN: 36AAACS3101P1ZE Email: info@everviehealth.com | Website: everviehealth.com